Results 121 to 130 of about 49,566 (218)

Seroepidemiology of hepatitis B virus (HBV) and relationship to serum transaminase levels in Indian population

Journal of Family Medicine and Primary Care
Background: Hepatitis B virus (HBV) infection is a serious public health issue that must be addressed. Aim: The goal of this study was to investigate the correlation between serological status for hepatitis Be antigen (HBeAg)/anti-HBe, serum transaminase
Manoj Kumar, Kumari Seema, Dinesh Kumar, Abhay Kumar, Ashok Kumar Sharma, Manju Boipai, Aysha Rani   +6 more
doaj   +1 more source

The possible impact of sortilin in reducing HBsAg expression in chronic hepatitis B [PDF]

, 2016
Hepatitis B virus (HBV) infection is a major global health problem. Chronically infected people are at risk for progressive hepatic fibrosis and consequent cirrhosis.
Besharat, S., Darvishi, Z., Katoonizadeh, A., Mohamadkhani, A., Moossavi, S., Poustchi, H., Roshandel, G.   +6 more
core  

Frekuensi HBsAg & PIBeAg pada ibu Hamil [PDF]

, 1994
HBeAg merupakan salah satu petanda serologik yang berhubungan dengan replikasi virus. Pemeriksaan HBeAg sangat penting untuk menentukan strategi pelaksanaan imunisasi.
Suparyatmo, JB
core  

Detection of HBV-DNA and Its Correlation with the HBeAg/Anti-HBe Serological Status in HBsAg-positive Patients [PDF]

, 2012
Background: In the past years, HBeAg and anti-HBe status in individuals with positive HBsAg were often correlated to viral replication. This study was aimed to find correlation between the HBV viremia and HBeAg/anti-HBe serological status in HBsAg ...
Gunawan, S. (Stephanus), Muttaqin, Z. (Zainul), Rhamdiani, S. O. (Shelly), Soemohardjo, S. (Soewignjo), Widita, H. (Haris), Wiguna, P. A. (Putu), Wijaya, M. (Mahendra)   +6 more
core  

Advances in immunomodulating therapy of HBV infection [PDF]

, 2000
Patients with chronic hepatitis B virus (HBV) infection have a higher risk of developing liver cirrhosis and hepatocellular carcinoma. Interferon-α, lamivudine and adefovir dipivoxil are the three approved treatment for chronic HBV infection and offers ...
Hui, CK, Lau, GKK
core  

Updates in the treatment of chronic hepatitis B [PDF]

, 2008
published_or_final_versio
Fung, J, Lai, CL, Yuen, MF
core  

经相同肝实质细胞体积分摊的血清HBsAg水平与肝组织病理进展相关而与HBeAg状态无关

Zhongshan Daxue xuebao. Yixue kexue ban, 2019
【目的】回顾性研究HBeAg阳性与HBeAg阴性慢性乙型病毒性肝炎之间，血清HBsAg的水平以及经相同肝实质细胞体积（肝细胞数量）分摊计算后血清HBsAg水平的异同。【方法】选取中山大学附属第三医院168例因病情需要而进行了肝穿刺活检及HBsAg定量检测的慢乙肝患者为研究对象。比较其HBeAg阳性与HBeAg阴性之间的血清HBsAg水平，以及经相同肝实质细胞体积（肝细胞数量）分摊计算后的血清HBsAg水平。【结果】血清HBsAg水平在HBeAg阳性和HBeAg阴性慢乙肝患者之间的差异有统计学意义（P=0.
doaj  

Anti‐viral therapy can be delayed or avoided in a significant proportion of HBeAg‐negative Caucasian patients in the Grey Zone

Alimentary Pharmacology and Therapeutics, 2018
M. Bonacci, S. Lens, Z. Mariño, M. Londoño, S. Rodríguez‐Tajes, Antoni Mas, M. García-López, S. Pérez‐del‐Pulgar, J. Sánchez‐Tapias, X. Forns   +9 more
semanticscholar   +1 more source

Trends in clinical intervention practice for preventing mother-to-child transmission of hepatitis B virus in Guangdong Province, 2021-2023. [PDF]

Hum Vaccin Immunother
Gao S, Xie T, Cai M, Su M, Zhao T, Zhang X, Zhang S, Wang M, Xu Q, Cheng Y, Cui F, Liu F.   +11 more
europepmc   +1 more source

Clinical superiority of HBV RNA testing in patients with chronic hepatitis B. [PDF]

Front Immunol
Zhou J, Li X, Yang Y, Wang X, Xu W.
europepmc   +1 more source